Catalyst
Slingshot members are tracking this event:
Impax Receives Tentative FDA Approval for Generic Version of Vytorin (ezetimibe and simvastatin) Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
IPXL |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 02, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Vytorin, Generic, Anda, Tentative Approval